The Cooper Companies, Inc. - Common Stock (COO)

Shares of medical device company CooperCompanies (NASDAQ:COO) jumped 3.5% in the morning session after its Board of Directors approved a $1 billion increase to the company's share repurchase program, bringing the total authorization to $2 billion. 

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

Shares of medical device company CooperCompanies (NASDAQ:COO) fell 3.2% in the afternoon session after Rothschild & Co Redburn lowered its price target on the stock to $92 from $95. 

Looking back on medical devices & supplies - diversified stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including CooperCompanies (NASDAQ:COO) and its peers.

Marvell, Hormel, and Keurig Dr Pepper led weekly large-cap losers on weak guidance and analyst downgrades.

Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.

The Cooper Companies (COO) are oversold and at support. These dynamics can set the stage for a new uptrend to form.

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Friday.

Sometimes it takes more than an earnings beat to make the market happy about a company.

Shares of medical device company CooperCompanies (NASDAQ:COO) fell 12.4% in the afternoon session after the company reported mixed second-quarter 2025 results, with its forecast for the upcoming quarter falling short of Wall Street's expectations. 

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.

Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights.

Medical device company CooperCompanies (NASDAQ:COO) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 5.7% year on year to $1.06 billion. On the other hand, next quarter’s revenue guidance of $1.06 billion was less impressive, coming in 2.8% below analysts’ estimates. Its non-GAAP profit of $1.10 per share was 3% above analysts’ consensus estimates.

Curious about the S&P500 stocks that are gapping on Thursday? Explore the gap up and gap down stocks in the S&P500 index during today's session.

Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.

Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Medical device company CooperCompanies (NASDAQ:COO) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 5.7% year on year to $1.06 billion. On the other hand, next quarter’s revenue guidance of $1.06 billion was less impressive, coming in 2.8% below analysts’ estimates. Its non-GAAP profit of $1.10 per share was 3% above analysts’ consensus estimates.